VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RBOT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RBOTVicarious Surgical Inc.
$0.00$9716
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRBOTP/E History

RBOT logoVicarious Surgical Inc. (RBOT) P/E Ratio History

Deep Value

Trading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2022–2022

Current P/E (TTM)
-0.0x
-100% vs 5Y avg
5Y Avg P/E
24.6x
Median 14.3x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-0.0x
Min4.7xMedian14.3xMax72.1x
TTM EPS$-6.29
Price$0.00
Earnings YieldN/A
EPS Growth (1Y)21.2%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of November 8, 2026, Vicarious Surgical Inc. (RBOT) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.00 and trailing twelve-month earnings per share of $-6.29.

The current P/E is 100% below its 5-year average of 24.6x. Over the past five years, RBOT's P/E has ranged from a low of 4.7x to a high of 72.1x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 24.6x, RBOT trades at a 100% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.

Relative to the broader market, RBOT trades at a notable discount to the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our RBOT DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

RBOT Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.0vs24.6
-100%
Below Sector
vs. S&P 500
-0.0vs21.8
-100%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 21% EPS growth (1Y)

RBOT P/E vs Peers

Surgical Robotics & Instruments peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ISRG logoISRGIntuitive Surgical, Inc.
$160B53.82.47+23%
SYK logoSYKStryker Corporation
$125B34.62.33+8%
MDT logoMDTMedtronic plc
$131B25.03.58+3%
GMED logoGMEDGlobus Medical, Inc.
$10B17.3Lowest0.56Best+423%Best
ABT logoABTAbbott Laboratories
$191B40.64.91-51%
BSX logoBSXBoston Scientific Corporation
$64B17.8-+55%
ZBH logoZBHZimmer Biomet Holdings, Inc.
$20B26.3--20%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

RBOT Historical P/E Data (2022–2022)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2022 Q4Dec 31 2022$60.60$0.8472.1x+194%
FY2022 Q3Sep 30 2022$100.50$21.214.7x-81%
FY2022 Q2-$88.20$12.517.1x-71%
FY2022 Q1-$151.80$10.6014.3x-42%

Average P/E for displayed period: 24.6x

Export Data
Consensus & Technical Research Suite
Open RBOT Terminal

RBOT Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

4+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

RBOT — Frequently Asked Questions

Quick answers to the most common questions about buying RBOT stock.

What is RBOT's P/E ratio?

Vicarious Surgical Inc. (RBOT) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-6.29. The 5-year average P/E is 24.6x and the historical range spans 4.7x to 72.1x.

Is RBOT stock overvalued or undervalued?

RBOT current P/E: -0.0x. 5-year average P/E: 24.6x. Percentile: 0th.

Is RBOT stock expensive?

RBOT is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 24.6x (0th percentile of historical range).

What is RBOT's historical P/E range?

Over the past 5 years, RBOT's P/E ratio has ranged from 4.7x to 72.1x, with a median of 14.3x and an average of 24.6x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2022–2022.

How does RBOT's P/E compare to the S&P 500?

RBOT current P/E: -0.0x. S&P 500 median P/E: 21.8x.

How does RBOT's valuation compare to Healthcare peers?

Vicarious Surgical Inc. P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.

What is RBOT's PEG ratio?

RBOT PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of 21.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is RBOT's earnings yield?

RBOT earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

RBOT P/E Ratio History (2022–2022)

Quarterly valuation multiple from closing price and trailing EPS

Current72.1x
Period Avg24.6x
Range4.7x - 72.1x
Change+404%
4 quartersMar 31, 2022 - Dec 31, 2022